Position in LH
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,973,160
+$79,877 QoQ
Shares Held
7,047
-0.7% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
#369
of 1,038 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Fragasso Financial Advisors Inc holds $5,684,240 across 5 Diagnostics & Research names. LH ranks #1 (34.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LH |
Labcorp Holdings Inc.
This page
|
7,047 | $1,973,160 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
3,197 | $1,602,847 | |
| 3 | DHR |
Danaher Corp /De/
|
7,916 | $1,507,839 | |
| 4 | CRL |
Charles River Laboratories International, Inc.
|
1,524 | $345,627 | |
| 5 | A |
Agilent Technologies, Inc.
|
1,918 | $254,767 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,973,160 | 7,047 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,893,283 | 7,096 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $1,808,092 | 7,207 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $2,138,884 | 7,451 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $2,138,931 | 8,148 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $2,101,176 | 9,028 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $2,670,431 | 11,645 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $2,866,131 | 12,825 | Shares | Sole | 2024-10-07 | |
| No filing history on record for this holder in this stock. | ||||||